8-K/A XBRL

FORM 8-K/A

Company: Petros Pharmaceuticals, Inc.
Filed: April 1, 2022
Period of Report: December 22, 2021
Accession Number: 0001104659-22-041818

View Document ↗ View on SEC.gov ↗